治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3233人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905077, encodeId=9c6219050e7b9, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA：抗生素疗法可作为非复杂阑尾炎患者的替代治疗方案, objectType=article, longId=149866, objectId=f2d61498669c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2d61498669c, replyNumber=0, likeNumber=100, createdTime=2018-11-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2d61498669c, moduleTitle=JAMA：抗生素疗法可作为非复杂阑尾炎患者的替代治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2d61498669c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905045, encodeId=16a8190504537, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳, objectType=article, longId=132175, objectId=88a01321e5e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a01321e5e9, replyNumber=0, likeNumber=72, createdTime=2018-08-13, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a01321e5e9, moduleTitle=JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88a01321e5e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905065, encodeId=1ac6190506577, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Hepatology：非酒精性脂肪性肝病和非酒精性脂肪性肝炎目前和未来的治疗方案, objectType=article, longId=145331, objectId=87c514533138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87c514533138, replyNumber=0, likeNumber=61, createdTime=2019-03-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87c514533138, moduleTitle=Hepatology：非酒精性脂肪性肝病和非酒精性脂肪性肝炎目前和未来的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87c514533138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905073, encodeId=5aaf19050e357, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Gastroenterol：炎症性肠病的全新治疗方案, objectType=article, longId=148039, objectId=37cc14803953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37cc14803953, replyNumber=0, likeNumber=79, createdTime=2019-06-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37cc14803953, moduleTitle=J Gastroenterol：炎症性肠病的全新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37cc14803953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905062, encodeId=d75c19050620e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=美国心血管疾病治疗方案数据过时上千万人或吃错药, objectType=article, longId=140684, objectId=e32e14068492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32e14068492, replyNumber=0, likeNumber=57, createdTime=2019-04-13, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32e14068492, moduleTitle=美国心血管疾病治疗方案数据过时上千万人或吃错药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32e14068492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905071, encodeId=ad0119050e195, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA Surg：全直肠系膜切除术治疗方案对直肠癌患者预后影响, objectType=article, longId=147211, objectId=a23114e2119b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a23114e2119b, replyNumber=0, likeNumber=69, createdTime=2018-09-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a23114e2119b, moduleTitle=JAMA Surg：全直肠系膜切除术治疗方案对直肠癌患者预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a23114e2119b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905082, encodeId=80be190508287, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=经加速审查 FDA批准两款癌症治疗方案, objectType=article, longId=154707, objectId=33f1154e0709, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33f1154e0709, replyNumber=0, likeNumber=47, createdTime=2019-01-13, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33f1154e0709, moduleTitle=经加速审查 FDA批准两款癌症治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33f1154e0709)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905056, encodeId=9039190505616, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, objectType=article, longId=138252, objectId=d2e11382522b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2e11382522b, replyNumber=0, likeNumber=0, createdTime=2018-05-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2e11382522b, moduleTitle=Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2e11382522b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905063, encodeId=0f0b190506343, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=用二甲双胍血糖仍不达标，5个案例分析如何调整治疗方案, objectType=article, longId=141933, objectId=0fac141933d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fac141933d9, replyNumber=0, likeNumber=118, createdTime=2019-03-02, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fac141933d9, moduleTitle=用二甲双胍血糖仍不达标，5个案例分析如何调整治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fac141933d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905041, encodeId=fb9a19050412b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=61, createdTime=2018-05-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905049, encodeId=6b2119050498d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：Pembro联合化疗：非鳞状NSCLC一线治疗方案, objectType=article, longId=135819, objectId=070e135819cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=070e135819cd, replyNumber=0, likeNumber=72, createdTime=2018-07-05, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=070e135819cd, moduleTitle=NEJM：Pembro联合化疗：非鳞状NSCLC一线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=070e135819cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905046, encodeId=a17f1905046f8, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Neurology：多发性硬化症女性避免妊娠期复发应采用哪一种治疗方案？, objectType=article, longId=132920, objectId=d96e132920f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d96e132920f2, replyNumber=0, likeNumber=106, createdTime=2018-09-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d96e132920f2, moduleTitle=Neurology：多发性硬化症女性避免妊娠期复发应采用哪一种治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d96e132920f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905042, encodeId=5a5f1905042c1, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=AM J CLIN NUTR :研究表明，新的治疗方案可以战胜高血压, objectType=article, longId=131311, objectId=c66f1313116c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c66f1313116c, replyNumber=0, likeNumber=81, createdTime=2018-10-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c66f1313116c, moduleTitle=AM J CLIN NUTR :研究表明，新的治疗方案可以战胜高血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c66f1313116c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905030, encodeId=fcc61905030fc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝, objectType=article, longId=122564, objectId=3ffa12256425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ffa12256425, replyNumber=0, likeNumber=72, createdTime=2018-11-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ffa12256425, moduleTitle=艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ffa12256425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905058, encodeId=168c19050589c, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Infect：中国多药耐药肺结核患者：标准二线治疗方案有多大作用？, objectType=article, longId=138500, objectId=a457138500ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a457138500ff, replyNumber=0, likeNumber=108, createdTime=2018-07-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a457138500ff, moduleTitle=J Infect：中国多药耐药肺结核患者：标准二线治疗方案有多大作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a457138500ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905051, encodeId=4018190505153, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Cabozantinib与舒尼替尼作为中度或低风险转移性肾细胞癌的最佳治疗方案（Alliance A031203 CABOSUN随机试验）：总生存期和无进展生存, objectType=article, longId=136870, objectId=65ff1368e0d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65ff1368e0d9, replyNumber=0, likeNumber=0, createdTime=2019-02-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65ff1368e0d9, moduleTitle=Cabozantinib与舒尼替尼作为中度或低风险转移性肾细胞癌的最佳治疗方案（Alliance A031203 CABOSUN随机试验）：总生存期和无进展生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65ff1368e0d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905076, encodeId=764f19050e6b2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=曼彻斯特大学医学研究获得新突破，高新石墨烯研发将改进脑癌治疗方案, objectType=article, longId=149173, objectId=8bd31491e382, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bd31491e382, replyNumber=0, likeNumber=62, createdTime=2019-03-09, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bd31491e382, moduleTitle=曼彻斯特大学医学研究获得新突破，高新石墨烯研发将改进脑癌治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bd31491e382)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905066, encodeId=1252190506663, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：儿童潜伏性结核分枝杆菌治疗方案——利福平vs异烟肼, objectType=article, longId=145684, objectId=369914568404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=369914568404, replyNumber=0, likeNumber=0, createdTime=2019-05-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=369914568404, moduleTitle=NEJM：儿童潜伏性结核分枝杆菌治疗方案——利福平vs异烟肼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=369914568404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905064, encodeId=4bf9190506457, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Nat Med：白血病细胞家谱绘制成功！改写传统治疗方案！, objectType=article, longId=144676, objectId=60671446e674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60671446e674, replyNumber=0, likeNumber=53, createdTime=2019-02-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60671446e674, moduleTitle=Nat Med：白血病细胞家谱绘制成功！改写传统治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60671446e674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905075, encodeId=b80319050e5e4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Clin Infect Dis：双氢青蒿素 - 哌喹治疗方案可以作为妊娠期妇女的间歇性疟疾预防方案, objectType=article, longId=148937, objectId=16a514893e57, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a514893e57, replyNumber=0, likeNumber=50, createdTime=2019-01-12, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a514893e57, moduleTitle=Clin Infect Dis：双氢青蒿素 - 哌喹治疗方案可以作为妊娠期妇女的间歇性疟疾预防方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a514893e57)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA：抗生素疗法可作为非复杂阑尾炎患者的替代治疗方案

2018-11-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA Intern Med：HIV阳性结核病患者每日抗结核药物治疗方案效果更佳

2018-08-13

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Hepatology：非酒精性脂肪性肝病和非酒精性脂肪性肝炎目前和未来的治疗方案

2019-03-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Gastroenterol：炎症性肠病的全新治疗方案

2019-06-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

美国心血管疾病治疗方案数据过时上千万人或吃错药

2019-04-13

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA Surg：全直肠系膜切除术治疗方案对直肠癌患者预后影响

2018-09-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

经加速审查 FDA批准两款癌症治疗方案

2019-01-13

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Liver Int：对采用以daclatasvir为基础治疗方案的HCV患者，进行长期随访

2018-05-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

用二甲双胍血糖仍不达标，5个案例分析如何调整治疗方案

2019-03-02

heli0118 (审核中...)

前往app查看评论内容

#治疗方案#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2018-05-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：Pembro联合化疗：非鳞状NSCLC一线治疗方案

2018-07-05

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Neurology：多发性硬化症女性避免妊娠期复发应采用哪一种治疗方案？

2018-09-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

AM J CLIN NUTR :研究表明，新的治疗方案可以战胜高血压

2018-10-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

艾伯维旗下维建乐®（奥比帕利片）联合易奇瑞®（达塞布韦钠片）治疗方案在华获批用于治疗基因1型慢性丙肝

2018-11-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Infect：中国多药耐药肺结核患者：标准二线治疗方案有多大作用？

2018-07-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Cabozantinib与舒尼替尼作为中度或低风险转移性肾细胞癌的最佳治疗方案（Alliance A031203 CABOSUN随机试验）：总生存期和无进展生存

2019-02-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

曼彻斯特大学医学研究获得新突破，高新石墨烯研发将改进脑癌治疗方案

2019-03-09

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：儿童潜伏性结核分枝杆菌治疗方案——利福平vs异烟肼

2019-05-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Nat Med：白血病细胞家谱绘制成功！改写传统治疗方案！

2019-02-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Clin Infect Dis：双氢青蒿素 - 哌喹治疗方案可以作为妊娠期妇女的间歇性疟疾预防方案

2019-01-12

科室
- - 订阅+
  - 更多科室
工具
服务